Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C11H17N |
| Molecular Weight | 163.2594 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCNC(C)CC1=CC=CC=C1
InChI
InChIKey=YAGBSNMZQKEFCO-UHFFFAOYSA-N
InChI=1S/C11H17N/c1-3-12-10(2)9-11-7-5-4-6-8-11/h4-8,10,12H,3,9H2,1-2H3
| Molecular Formula | C11H17N |
| Molecular Weight | 163.2594 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Etilamfetamine (Apetinil) is a stimulant drug of amphetamine chemical class. It is an N-substituted amphetamine with an ethyl group on the amphetamine backbone. It was used as an anorectic or appetite suppressant. Etilamfetamine is a psychoactive drug, which can be used as a recreational drug. Etilamfetamine has been abused as a “designer drug” alternative to amphetamine and possibly methamphetamine. It is a dopamine releasing agent.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| LC-MS/MS screening method for designer amphetamines, tryptamines, and piperazines in serum. | 2010-04 |
|
| MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist. | 2005-11-03 |
|
| Impurity profiling of methamphetamine hydrochloride drugs seized in the Philippines. | 2004-08-11 |
|
| Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. | 2003-06 |
|
| Precursor medications as a source of methamphetamine and/or amphetamine positive drug testing results. | 2002-05 |
|
| Toxicokinetics of amphetamines: metabolism and toxicokinetic data of designer drugs, amphetamine, methamphetamine, and their N-alkyl derivatives. | 2002-04 |
|
| Evaluating the separation of amphetamines by electrospray ionization ion mobility spectrometry/MS and charge competition within the ESI process. | 2002-01-15 |
|
| Evaluation of Roche Abuscreen ONLINE amphetamine immunoassay for screening of new amphetamine analogues. | 2001-09 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2767582
Rats (Wistar) were injected intraperitoneally with 25 mg ethylamphetamine hydrochloride per kg.
Route of Administration:
Intraperitoneal
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:12:01 GMT 2025
by
admin
on
Mon Mar 31 18:12:01 GMT 2025
|
| Record UNII |
022YON1XMX
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DEA NO. |
1475
Created by
admin on Mon Mar 31 18:12:01 GMT 2025 , Edited by admin on Mon Mar 31 18:12:01 GMT 2025
|
||
|
WHO-ATC |
A08AA06
Created by
admin on Mon Mar 31 18:12:01 GMT 2025 , Edited by admin on Mon Mar 31 18:12:01 GMT 2025
|
||
|
WHO-VATC |
QA08AA06
Created by
admin on Mon Mar 31 18:12:01 GMT 2025 , Edited by admin on Mon Mar 31 18:12:01 GMT 2025
|
||
|
NCI_THESAURUS |
C47795
Created by
admin on Mon Mar 31 18:12:01 GMT 2025 , Edited by admin on Mon Mar 31 18:12:01 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DB13285
Created by
admin on Mon Mar 31 18:12:01 GMT 2025 , Edited by admin on Mon Mar 31 18:12:01 GMT 2025
|
PRIMARY | |||
|
100000078996
Created by
admin on Mon Mar 31 18:12:01 GMT 2025 , Edited by admin on Mon Mar 31 18:12:01 GMT 2025
|
PRIMARY | |||
|
C81050
Created by
admin on Mon Mar 31 18:12:01 GMT 2025 , Edited by admin on Mon Mar 31 18:12:01 GMT 2025
|
PRIMARY | |||
|
457-87-4
Created by
admin on Mon Mar 31 18:12:01 GMT 2025 , Edited by admin on Mon Mar 31 18:12:01 GMT 2025
|
PRIMARY | |||
|
Etilamfetamine
Created by
admin on Mon Mar 31 18:12:01 GMT 2025 , Edited by admin on Mon Mar 31 18:12:01 GMT 2025
|
PRIMARY | |||
|
m5088
Created by
admin on Mon Mar 31 18:12:01 GMT 2025 , Edited by admin on Mon Mar 31 18:12:01 GMT 2025
|
PRIMARY | Merck Index | ||
|
1100
Created by
admin on Mon Mar 31 18:12:01 GMT 2025 , Edited by admin on Mon Mar 31 18:12:01 GMT 2025
|
PRIMARY | |||
|
DTXSID10860359
Created by
admin on Mon Mar 31 18:12:01 GMT 2025 , Edited by admin on Mon Mar 31 18:12:01 GMT 2025
|
PRIMARY | |||
|
SUB13752MIG
Created by
admin on Mon Mar 31 18:12:01 GMT 2025 , Edited by admin on Mon Mar 31 18:12:01 GMT 2025
|
PRIMARY | |||
|
9982
Created by
admin on Mon Mar 31 18:12:01 GMT 2025 , Edited by admin on Mon Mar 31 18:12:01 GMT 2025
|
PRIMARY | |||
|
CHEMBL276443
Created by
admin on Mon Mar 31 18:12:01 GMT 2025 , Edited by admin on Mon Mar 31 18:12:01 GMT 2025
|
PRIMARY | |||
|
022YON1XMX
Created by
admin on Mon Mar 31 18:12:01 GMT 2025 , Edited by admin on Mon Mar 31 18:12:01 GMT 2025
|
PRIMARY | |||
|
4532
Created by
admin on Mon Mar 31 18:12:01 GMT 2025 , Edited by admin on Mon Mar 31 18:12:01 GMT 2025
|
PRIMARY | |||
|
C016434
Created by
admin on Mon Mar 31 18:12:01 GMT 2025 , Edited by admin on Mon Mar 31 18:12:01 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PRECURSOR->PARENT |
|
||
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |